Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Frontiers in Oncology|September 16, 2017
Propensity Score Matched Comparison of Intensity Modulated Radiation Therapy vs Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Survival Analysis from the National Cancer DatabaseAnthony Ricco, Alexandra Hanlon, Rachelle LancianoAmerican Journal of Obstetrics and Gynecology|January 2, 2010
Smoking behavior in women with locally advanced cervical carcinoma: a Gynecologic Oncology Group studySteven E Waggoner, Kathleen M Darcy, Chunqiao Tian, et al.Gynecologic Oncology|February 6, 2007
Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trialsBradley J Monk, Chunqiao Tian, Peter G Rose, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2009
Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: a gynecologic oncology group studyCharles Kunos, Chunqiao Tian, Steven Waggoner, et al.International Journal of Radiation Oncology, Biology, Physics|December 19, 2012
Effect of fractionation in stereotactic body radiation therapy using the linear quadratic modelJun Yang, John Lamond, Jack Fowler, et al.Cancer|March 15, 2008
Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group StudyMichael A Gold, Chunqiao Tian, Charles W Whitney, et al.Gynecologic Oncology|February 26, 2010
Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group studyPeter G Rose, Shamshad Ali, Charles W Whitney, et al.Gynecologic Oncology|March 23, 2011
Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group studyPeter G Rose, Shamshad Ali, Charles W Whitney, et al.Frontiers in Oncology|May 31, 2012
Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumorsRachelle Lanciano, John Lamond, Jun Yang, et al.International Journal of Radiation Oncology, Biology, Physics|April 20, 2010
Red shell: defining a high-risk zone of normal tissue damage in stereotactic body radiation therapyJun Yang, Jack F Fowler, John P Lamond, et al.Pageof 4